Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Nintendo preservationist Forest of Illusion recently shared information gleaned from an old ...
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) announced today that the first patient has been dosed in a first-in-human phase 1/2 trial evaluating DS-3939 in patients with ...
TOKYO, BASKING RIDGE, N.J. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) and Sarah Cannon Research Institute (SCRI) announced that extended follow-up data from a phase 1/2 trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results